Scientists answer hotly debated questions about how calorie restriction delays aging process September 3, 2013 By Lee Phillion Among scientists, the role of proteins called sirtuins in enhancing longevity has been hotly debated, driven by contradictory results from… Read More ›
Washington University School of Medicine
Tumors disable immune cells by using up sugar
Contact: Michael C. Purdy purdym@wustl.edu 314-286-0122 Washington University School of Medicine Cancer cells’ appetite for sugar may have serious consequences for immune cell function, researchers at Washington University School of Medicine in St. Louis have learned. The scientists found that… Read More ›
Nanoparticles loaded with bee venom kill HIV
March 7, 2013 By Julia Evangelou Strait Joshua L. Hood, MD, PhD Nanoparticles (purple) carrying melittin (green) fuse with HIV (small circles with spiked outer ring), destroying the virus’s protective envelope. Molecular bumpers (small red ovals) prevent the nanoparticles… Read More ›
Emerging cancer drugs may drive bone tumors
February 12, 2013 By Julia Evangelou Strait Chang Yang, MD, PhD Investigational cancer drugs, IAP antagonists, may increase the risk of tumors spreading to bone. Tumors often cause bone loss, but IAP antagonist treatment accelerates the problem. Cancer drugs… Read More ›
Ingredient in red wine may prevent some blinding diseases
2010 study posted for filing Resveratrol inhibits formation of damaging blood vessels in mouse retina By Jim Dryden Resveratrol — found in red wine, grapes, blueberries, peanuts and other plants — stops out-of-control blood vessel growth in the… Read More ›
76th Health Research Report 25 FEB 2010 – Reconstruction
Top Five: 1. Bitter melon extract attacks breast cancer cells 2. Vitamin B3 shows early promise in treatment of stroke 3. New evidence that green tea may help fight glaucoma and other eye diseases 4. Lactobacillus improves Helicobacter… Read More ›
Alzheimer’s disease may protect against cancer and vice versa
2009 study posted for filing Contact: Rachel Seroka rseroka@aan.com 651-695-2738 American Academy of Neurology ST. PAUL, Minn. – People who have Alzheimer’s disease may be less likely to develop cancer, and people who have cancer may be less likely to… Read More ›
Mice at risk of asthma, allergies can fight off skin cancer
Contact: Julia Evangelou Strait straitj@wustl.edu 314-286-0141 Washington University School of Medicine A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in… Read More ›
Diverse intestinal viruses may play a role in AIDS progression
Contact: Elisabeth Lyons elyons@cell.com 617-386-2121 Cell Press In monkeys and humans with AIDS, damage to the gastrointestinal tract is common, contributing to activation of the immune system, progressive immune deficiency, and ultimately advanced AIDS. How this gastric damage occurs has… Read More ›
Natural compound helps reverse diabetes in mice – nicotinamide mononucleotide / NAD
Contact: Julia Evangelou Strait straitj@wustl.edu 314-286-0141 Washington University School of Medicine Natural compound helps reverse diabetes in mice Researchers at Washington University School of Medicine in St. Louis have restored normal blood sugar metabolism in diabetic mice using a compound… Read More ›
Study shows no evidence of a mortality benefit to PSA screening
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the… Read More ›
Chemotherapy contributes to relapse in cancer patients by damaging DNA and generating new mutations that allow tumor cells to evolve and become resistant to treatment.
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest. The research, by… Read More ›
Engineering Evil 